ILLISIA JOHNSTON: Open Payments
NPI 1003486556 · LAUREL, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$286 in 17 payments from 4 companies in 2025. Trend: 2023 $1,707 · 2024 $440 · 2025 $286
Food & beverage: $286
| Company | Payments | Amount |
|---|---|---|
| Octapharma USA, Inc. | 5 | $111 |
| Lilly USA, LLC | 7 | $84 |
| Novo Nordisk Inc | 4 | $71 |
| Ardelyx, Inc. | 1 | $19 |
Products named: PANZYGA, MOUNJARO, Wegovy, IBSRELA, Ozempic, ZEPBOUND.
Industry payments across MS — which companies pay providers there.
